Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The purpose of this study is to find out if the two different formulations of exemestane (Aromasin), oral and injectable, are equivalent in terms of pharmacodynamics and pharmacokinetics, i.e., if ultimately both formulations have the same efficacy in postmenopausal women with metastatic breast cancer who have failed previous antiestrogens therapy and are equally safe.
Epistemonikos ID: 0c85f28c717075f7503ea512da3f254d279f5536
First added on: May 03, 2024